Fidelity Select Biotechnology Portfolio
FBIOX
NASDAQ
Weiss Ratings | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Company Info | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Fidelity Investments | |||
Manager/Tenure (Years) | Rajiv Kaul (19) | |||
Website | http://www.institutional.fidelity.com | |||
Fund Information | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Fidelity Select Biotechnology Portfolio | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Health | |||
Inception Date | Dec 16, 1985 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 0.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 1.17% | |||
Dividend | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 1.03% | |||
Asset Allocation | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 0.15% | |||
Stock | 97.23% | |||
U.S. Stock | 84.68% | |||
Non-U.S. Stock | 12.55% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 2.62% | |||
Price History | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -2.03% | |||
30-Day Total Return | -1.43% | |||
60-Day Total Return | -0.05% | |||
90-Day Total Return | -5.90% | |||
Year to Date Total Return | 1.64% | |||
1-Year Total Return | -1.71% | |||
2-Year Total Return | 20.54% | |||
3-Year Total Return | 28.81% | |||
5-Year Total Return | 23.08% | |||
Price | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | -- | |||
1-Month Low NAV | $19.15 | |||
1-Month High NAV | $20.17 | |||
52-Week Low NAV | $17.43 | |||
52-Week Low NAV (Date) | Apr 19, 2024 | |||
52-Week High NAV | $22.47 | |||
52-Week High Price (Date) | Nov 08, 2024 | |||
Beta / Standard Deviation | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.59 | |||
Standard Deviation | 19.98 | |||
Balance Sheet | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 4.28B | |||
Operating Ratios | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.66% | |||
Turnover Ratio | 52.00% | |||
Performance | FBIOX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 18.89% | |||
Last Bear Market Total Return | -10.44% | |||